ASCO GU Symposium announces new findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...
Metastatic bladder cancer immunotherapy outcomes better with antihistamines, study shows
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...
Cure Today13h
Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
The American Journal of Managed Care16h
Ovarian Cancer Remission Rates Remained Stable Before, After COVID-19 Pandemic
The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...
Cure Today16h
Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes Status
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study underscore the critical role of tumor size ...